跳至主要内容
临床试验/NCT04749979
NCT04749979Unknown不适用

Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin in IVF Cycles

Aljazeera Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年2月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
the number of good quality embryos

研究概览

简要总结

Estradiol valerate in the form of cycloprogenova™ (white tablet only) was started on day 2 or 3 of cycle with oral dose 4 mg divided on 2 doses in addition to Aspocid 75 mg once daily with folic acid 500 mcg once daily.

详细描述

U/S was done on day 9 or 10 of cycle to assess endometrial thickness, then every other day until endometrial thickness of 8 mm or more is reached and when endometrial thickness reaches 8 mm or more FET was planned. Progesterone in the form of prontogest™ 400 mg vaginal suppository twice dTwo to Four Day 5 Embryos was transferred

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • PCOS patients according to Rotterdam criteria
  • Female age between 20 and 40 years.
  • Primary or secondary infertility.
  • Body mass index (BMI) between 18 and 40 kg/m2.

排除标准

  • Ovarian endometriosis.
  • Ovarian cysts before induction.
  • Known uncontrolled endocrinal abnormalities (like hypo or hyperthyroidism)

研究组 & 干预措施

giving agonist ( eg. decapeptyl )

Active Comparator

Giving women agonist

干预措施: Agonist (decapeptyl ) (Drug)

Giving HCG (eg. choriomon )

Active Comparator

Giving women HCG

干预措施: HCG ( eg. Choriomon ) (Drug)

结局指标

主要结局

the number of good quality embryos

时间窗: within 5 months

how many good quality embryos

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验